Kim Hin Industry Berhad (KLSE:KIMHIN)

Checkpoint Therapeutics Ratios and Metrics

Market cap in millions MYR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	119	71	77	82	122	114
Market Cap Growth	-28.18%	-8.18%	-5.98%	-32.76%	7.41%	-22.86%
Enterprise Value	113	72	99	124	123	83
Last Close Price	0.85	0.51	0.55	0.58	0.87	0.79
PS Ratio	0.41	0.23	0.25	0.24	0.36	0.34
PB Ratio	0.43	0.26	0.25	0.24	0.32	0.28
P/TBV Ratio	0.46	0.27	0.27	0.26	0.35	0.30
P/FCF Ratio	7.34	7.42	7.51	-	-	35.33
P/OCF Ratio	6.27	5.48	3.95	-	-	6.34
EV/Sales Ratio	0.39	0.23	0.32	0.36	0.36	0.25
EV/FCF Ratio	6.97	7.59	9.65	-	-	25.79
Debt / Equity Ratio	0.13	0.11	0.17	0.17	0.18	0.11
Debt / FCF Ratio	2.11	3.29	4.94	-	-	14.45
Asset Turnover	0.71	0.76	0.67	0.67	0.63	0.61
Inventory Turnover	2.03	2.21	2.07	2.08	2.06	1.97
Quick Ratio	1.06	1.06	1.02	0.89	1.06	1.32
Current Ratio	2.19	2.29	2.12	2.17	2.29	2.54
Return on Equity (ROE)	-9.73%	-9.63%	-12.26%	-8.94%	-8.26%	-2.23%
Return on Assets (ROA)	-3.94%	-3.93%	-6.81%	-3.87%	-3.76%	-4.13%
Return on Capital (ROIC)	-4.87%	-4.79%	-8.21%	-4.65%	-4.54%	-4.91%
Earnings Yield	-24.70%	-41.24%	-48.26%	-39.50%	-27.12%	-12.64%
FCF Yield	13.63%	13.48%	13.32%	-23.15%	-18.02%	2.83%
Dividend Yield	-	-	-	-	2.30%	2.53%
Total Shareholder Return	-	-	-	-	2.30%	2.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.